# I.Q. Endoscopes

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/i-q-endoscopes

- Industry: Medical Devices & Equipment
- Headquarters: Chepstow, UK
- Website: www.iqendoscopes.com/
- Total disclosed funding: $12M
- Latest round: Series B (Dec 21, 2022)
- Investors on record: 5

## About

Based in the UK and founded in 2015 by Dr Patrick Ward-Booth, IQ Endoscopes Limited provides endoscope services to clinical, medtech, and engineering specialists focused on providing single-use endoscopes. Matthew Ginn serves as the CEO of the company. In March 2026, IQ Endoscopes Limited raised venture funding led by BGF Investment Management, with participation from Development Bank of Wales. The company offers sterile endoscopes that are designed to limit the danger of cross-infection while also increasing capacity. The firm develops possibilities for use in non-endoscopy settings such as ITU, outpatients, ward settings, and community health. IQ Endoscope’s technology eliminates for health organizations the substantial and recurring expenditures of purchasing, cleaning, and maintaining standard scopes. The company will use the March 2026 funding to support early commercial rollout in selected UK centers, strengthen manufacturing and supply chain capability, build a commercial pipeline, and advance regulatory work and market validation in the US.

## Funding rounds

- Series B, Dec 21, 2022, $6.3M — BGF Investment Management, Development Bank of Wales
- Series A, Apr 4, 2021, $5.5M — Development Bank of Wales, Creo Medical Group PLC, Australian Unity, Nepcoe Capital Partners

## Investors

- Development Bank of Wales (https://capitalatlas.ai/funds/development-bank-of-wales) — Series A, Series B
- Creo Medical Group PLC — Series A
- Australian Unity (https://capitalatlas.ai/funds/australian-unity) — Series A
- Nepcoe Capital Partners — Series A
- BGF Investment Management (https://capitalatlas.ai/funds/bgf-investment-management) — Series B